Effectiveness and Impact of Nirsevimab on medium to long-term RSV associated outcomes in Finland – Population-based registry study (RSV506)

First published 11/08/2026

Last updated 11/08/2026

EU PAS number:

EUPAS1000001045

Study

Planned

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Effectiveness and Impact of Nirsevimab on medium to long-term RSV associated outcomes in Finland – Population-based registry study (RSV506)

Secondary tabs

Share this page